Promimic
Promimic uses nanotechnology to create a bioactive surface on any implant, accelerating bone growth with medical device partners.
- Public company
- Mölndal, SESweden
Promimic uses nanotechnology to create a bioactive surface on any implant, accelerating bone growth with medical device partners.
Which advantages over its rivals hold up, and why are they hard to copy?
Promimic's HAnano Surface outperforms traditional coatings because bone meets the implant directly rather than through a coating layer, and its particle-based design carries no risk of cracking or delamination.
More than 30 in vivo and in vitro studies demonstrate that the surface accelerates bone growth. Applications span dental, spine, total joint, extremities, and sports medicine implant markets.
How does it win customers, and through which channels?
Promimic wins orthopedic and dental implant customers by licensing its HAnano Surface to those companies and partnering with medical device companies through all phases of product development and commercialization rather than selling to them directly.
The technology is proven in over 30 scientific studies and with over 900,000 implants in clinical use. Danco Medical has been the preferred processing partner for Promimic's US customers since 2016.
What could change its growth trajectory, and what would confirm it?
New device clearances are the indicator to watch for Promimic's growth. Promimic and Curiteva worked together to incorporate the surface technology with a 3D-printed porous PEEK cervical implant for spinal fusion. Promimic's product applications cover the dental, spine, total joint, extremities, and sports medicine implant markets.
Over 30 in vivo and in vitro studies demonstrate that the surface accelerates bone growth. A joint venture holds dedicated processing capabilities at a Danco Medical facility in Warsaw, Indiana.
What does the product do for its buyer, and how is it delivered?
HAnano Surface is a 20-nanometre modification of implant surfaces using crystalline hydroxyapatite particles, which Promimic licenses to orthopedic and dental implant companies as the basis of its business model, with the modification applied through a wet chemical process.
Promimic works with medical device companies through each phase of product development and commercialization.